Responses
Inflammatory Bowel Disease I
PTU-073 Efficacy and safety of granulocyte, monocyte/macrophage adsorptive apheresis in steroid-dependent active uc with insufficient response or intolerance to immunosuppressants and/or biological therapies -the art trial: 24 and 48 week results
Compose a Response to This Article
Other responses
No responses have been published for this article.